Reply to “FromMechanism to Implementable Benefit: Decision-Grade Inflammasome Modulation for Salmonella Control”
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-11643-y ↗Kurz gefasst
Leserbrief in der Zeitschrift Molecular Biology Reports, online erschienen am 05.03.2026. Verfasst von Yeling He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, Gansu, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, Gansu, China.
- Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, Gansu, China. yangjing0502@lzu.edu.cn.
Zitieren
APA
He, Y., Ding, D., Guo, J., Sun, H., & Yang, J. (2026). Reply to “FromMechanism to Implementable Benefit: Decision-Grade Inflammasome Modulation for Salmonella Control”. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-11643-y
Vancouver
He Y, Ding D, Guo J, Sun H, Yang J. Reply to “FromMechanism to Implementable Benefit: Decision-Grade Inflammasome Modulation for Salmonella Control”. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-11643-y
BibTeX
@article{He2026,
author = {He, Yeling and Ding, Dandan and Guo, Jiayin and Sun, Hui and Yang, Jing},
title = {Reply to “FromMechanism to Implementable Benefit: Decision-Grade Inflammasome Modulation for Salmonella Control”},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-11643-y}
}
EUVIMED